Office of Research & Development |
![]() ![]() |
Project Number: | I01BX003625-01A1 |
Title: | The role of ADAR2-associated RNA editing in pathogenesis of ALS |
Principal Investigator: | Stella Plevan (Dracheva) |
Location: | Bronx, NY |
Congressional District Code: | 13 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2017 - September 2021 |
FY 2021 Funding Amount: | $356,837 |
Total Award Amount (all years): |
$1,406,624 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Amyotrophic Lateral Sclerosis (ALS) is a devastating and fatal neurodegenerative disease that is characterized by progressive muscle weakness and eventual paralysis. The known risk factors for ALS are increasing age and male sex; recent data also implicate military service, thus putting an additional burden on the VA healthcare system. Approximately 90% of all ALS cases are classified as sporadic ALS (sALS) with no family history of the disease. The remaining cases are inherited in a dominant fa... |